TO STUDY THE EFFECT OF AYURVEDIC MEDICINE ELADI CHURNA AND DRAKSHARISHTA FOR THE TREATMENT OF KASA (CHRONIC COUGH)

Phase 2

Completed

• Conditions: Health Condition 1: null- Kasa (Stable Chronic Bronchitis)

• Registration Number: CTRI/2018/07/014714
• Lead Sponsor: Central Council for Research in Ayurvedic Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-04-27
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 105

Inclusion Criteria

1.Age of the patient is between 18 to 65 years.

2.Patients of chronic stable bronchitis suffering from minimum of two years.(Chronic bronchitis is defined clinically as chronic Productive cough for 3 months in each of 2 successive years in that patient in whom other causes of productive cough have been excluded.)

3.Stable symptoms for the past 2 weeks i.e. unchanged amount & color of daily sputum

4. FEV1 of > 80%

5.Patient willing and able to participate in the study for 16 weeks.

Exclusion Criteria

1.Patient is having another diagnosed pulmonary disorder (E.g. Emphysema, cor pulmonale, cyanosis, pneumonia, asthma, cystic fibrosis, tuberculosis, lung cancer etc.)

2.Patient of Diabetes Mellitus

3.Patient is having poorly controlled HTN (BP >= 160/100 mmHg).

4.Patient is on prolonged ( > 6 Weeks) medication with corticosteroids, bronchodilators, mast-cell stabilizers, antidepressants, anticholinergics etc. or any other drugs that may have an influence on the outcome of the study

5.Patient is suffering from major systemic illness necessitating long term drug treatment (e.g. Rheumatoid arthritis, Tuberculosis & psycho-neuro-endocrinal disorders etc.)

6.Patient is having the past history of atrial fibrillation, acute coronary syndrome, MI, stroke or severe arrhythmia in the last 6 months.

7.Patient is having symptoms of heart failure along with clinical evidences.

8.Patients is suffering from concurrent serious hepatic disorder (AST &/or ALT, Total Bilirubin & ALP > 2 times upper normal limit) or renal disorder (S. creatinine > 1.2 mg/dl).

9.Patient is a smoker/alcoholic &/or drug abuser.

10.Patient has completed participation in another clinical trial during the past six months.

11.Patientâ??s condition which may jeopardize the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified